1-5 of 5
Evanthia T. Roussos Torres
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myeloid-Derived Suppressor–Cell Dynamics Control Outcomes in the Metastatic Niche

Jesse Kreger, Evanthia T. Roussos Torres, Adam L. MacLean
Journal: Cancer Immunology Research
Cancer Immunol Res (2023) 11 (5): 614–628.
https://doi.org/10.1158/2326-6066.CIR-22-0617
Published: 03 May 2023
View article titled, Myeloid-Derived Suppressor–Cell Dynamics Control Outcomes in the Metastatic Niche
Open the PDF for Myeloid-Derived Suppressor–Cell Dynamics Control Outcomes in the Metastatic Niche in another window
Includes: Supplementary data
Journal Articles

Abstract A17: Development of a 3D tunable platform to measure the impact of patient-derived organoids on macrophage polarization

Chun-Te Chiang, Danielle Hixon, Nevart Mooradian, Seungil Kim, Aaron G. Baugh, Evanthia T. Roussos Torres, Shannon M. Mumenthaler
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (12_Supplement): A17.
https://doi.org/10.1158/2326-6074.TUMIMM22-A17
Published: 01 December 2022
View article titled, Abstract A17: Development of a 3D tunable platform to measure the impact of patient-derived organoids on macrophage polarization
Journal Articles

Revival and Recharacterization of a Preclinical Model of Hormone-Dependent Breast Cancer to Study Immunotherapy

Evanthia T. Roussos Torres
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (6): 672–673.
https://doi.org/10.1158/2326-6066.CIR-22-0315
Published: 03 June 2022
View article titled, Revival and Recharacterization of a Preclinical Model of Hormone-Dependent Breast Cancer to Study Immunotherapy
Open the PDF for Revival and Recharacterization of a Preclinical Model of Hormone-Dependent Breast Cancer to Study Immunotherapy in another window
Journal Articles

Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment

Dimitrios N. Sidiropoulos, Christine I. Rafie, Julie K. Jang, Sofi Castanon, Aaron G. Baugh, Edgar Gonzalez, Brian J. Christmas, Valerie H. Narumi, Emily F. Davis-Marcisak, Gaurav Sharma, Emma Bigelow, Ajay Vaghasia, Anuj Gupta, Alyza Skaist, Michael Considine, Sarah J. Wheelan, Sathish Kumar Ganesan, Min Yu, Srinivasan Yegnasubramanian, Vered Stearns, Roisin M. Connolly, Daria A. Gaykalova, Luciane T. Kagohara, Elizabeth M. Jaffee, Elana J. Fertig, Evanthia T. Roussos Torres
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (5): 656–669.
https://doi.org/10.1158/2326-6066.CIR-21-0170
Published: 03 May 2022
View article titled, Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2<sup>+</sup> Breast Tumor Microenvironment
Open the PDF for Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2<sup>+</sup> Breast Tumor Microenvironment in another window
Includes: Supplementary data
Journal Articles

Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs

Brian J. Christmas, Christine I. Rafie, Alexander C. Hopkins, Blake A. Scott, Hayley S. Ma, Kayla A. Cruz, Skylar Woolman, Todd D. Armstrong, Roisin M. Connolly, Nilo A. Azad, Elizabeth M. Jaffee, Evanthia T. Roussos Torres
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (12): 1561–1577.
https://doi.org/10.1158/2326-6066.CIR-18-0070
Published: 03 December 2018
View article titled, Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
Open the PDF for Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs in another window
Includes: Supplementary data